Home NDC 0009-0746 Depo-Provera
Product NDC 0009-0746
11-digit product format 000090746
Labeler code 0009
Product ID 0009-0746_048d453b-e149-464e-99a9-97b2db8582c9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name medroxyprogesterone acetate
Dosage form INJECTION, SUSPENSION
Route INTRAMUSCULAR
Labeler Pharmacia & Upjohn Company LLC
Application NDA020246
Marketing category NDA
Marketing start 1992-10-29
Substance MEDROXYPROGESTERONE ACETATE
Active strength 150 mg/mL
Pharmacologic classes Progesterone Congeners [CS], Progestin [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020246-001 DEPO-PROVERA MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020246-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Depo-Provera
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MEDROXYPROGESTERONE ACETATE 150 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination C2QI4IOI2G Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1000126 Internal RxNorm lookup 1000128 Internal RxNorm lookup 1000153 Internal RxNorm lookup 1000154 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0009-0746-30 Depo-Provera 1 in 1 CARTON INJECTION, SUSPENSION 1 28 0009-0746-30 Depo-Provera 1 mL in 1 VIAL INJECTION, SUSPENSION 1 28 0009-0746-35 Depo-Provera 25 in 1 PACKAGE INJECTION, SUSPENSION 25 28 0009-0746-35 Depo-Provera 1 mL in 1 VIAL INJECTION, SUSPENSION 1 28
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT C2QI4IOI2G DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 MEDROXYPROGESTERONE ACTIVE MOIETY HSU1C9YRES DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14 WATER INACTIVE INGREDIENT 059QF0KO0R DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0009-0746 DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA & UPJOHN COMPANY LLC] 26 Current NDC, Legacy NDC, 4 package rows 20240801_199cf13e-0859-4a73-9b45-e700d0cd1049.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join medroxyprogesterone acetate MEDROXYPROGESTERONE ACETATE Prasco Laboratories 987496bf-b4b0-409b-b745-f52ed0871f4e 2026-07-21 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020246 application number: NDA020246 medroxyprogesterone acetate MEDROXYPROGESTERONE ACETATE A-S Medication Solutions 5e817926-ba15-4d16-9463-88f6ff3bd3ac 2026-02-23 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020246 application number: NDA020246 Depo-Provera MEDROXYPROGESTERONE ACETATE Pharmacia & Upjohn Company LLC 199cf13e-0859-4a73-9b45-e700d0cd1049 2025-12-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020246 application number: NDA020246 ndc (product): 0009-0746 medroxyprogesterone acetate MEDROXYPROGESTERONE ACETATE A-S Medication Solutions ca344c55-5251-470f-9243-eceb9e496e3e 2023-10-23 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020246 application number: NDA020246
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0009-0746-30 00009074630 1 VIAL in 1 CARTON (0009-0746-30) / 1 mL in 1 VIAL 1 vial 1992-10-29 0000-00-00 No No Current 0009-0746-35 00009074635 25 VIAL in 1 PACKAGE (0009-0746-35) / 1 mL in 1 VIAL 25 vial 1992-10-29 0000-00-00 No No Current